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To assess whether infants hospitalized after an appar-
ently life-threatening event had an associated respiratory 
virus infection, we analyzed nasopharyngeal aspirates from 
16	patients.	Nine	of	11	infants	with	positive	virus	results	
were infected by rhinoviruses. We detected the new geno-
group	of	rhinovirus	C	in	6	aspirates.
H
uman  rhinovirus  (HRV)  is  1  of  the  most  common 
agents  associated  with  upper  and  lower  respiratory 
tract infections in children and infants (1) and is a major 
trigger of asthma exacerbations (2). Recently, molecular 
methods have shown substantial phenotypic variation of 
HRV and identified a novel HRV genogroup provisionally 
named HRV-C (3). Severe asthma exacerbations in children 
have been associated with this new genogroup of rhinovi-
ruses. Genogroup C could be resistant to a new candidate 
group of antipicornavirus drugs, including pleconaril (4).
Apparently life-threatening events (ALTEs) in infants 
are associated with bronchiolitis or infections in up to 6% 
of patients by diagnosis after hospital admission (5). We 
assessed the relation between ALTEs and respiratory virus 
infection in a secondary hospital in Spain.
The Study
Our study was part of a systematic prospective study 
to assess the epidemiology of respiratory virus infections in 
children admitted to the Severo Ochoa Hospital (Leganés, 
Madrid Province, Spain).We conducted a specific study to 
determine the incidence of respiratory virus infections in 
all infants admitted after ALTEs during November 2004–
December 2008. An ALTE in a child <1 year of age was 
defined as an episode that is frightening to the observer and 
characterized by some combination of apnea, color change, 
marked change in muscle tone, choking, or gagging so the 
observer fears the infant has died (6).
Nasopharyngeal aspirate (NPA) specimens were ac-
quired from each eligible patient at the time of hospital 
admission  (on  Monday–Friday).  Samples  were  sent  for 
virologic  study  to  the  Influenza  and  Respiratory  Virus 
Laboratory (National Centre for Microbiology, Institute of 
Health Carlos III, Spain). Specimens were processed with-
in 24 hours after collection.
Total nucleic acids were extracted from 200-µL ali-
quots by using a QIAamp MinElute Virus Spin Kit in a 
QIAcube  automated  extractor  (QIAGEN,  Valencia,  CA, 
USA).  Simple  or  multiplex  reverse  transcription–nested 
PCR  assays  (RT-PCR)  previously  described  (7–9)  were 
used to assess the virus diagnosis, including 16 respiratory 
viruses or groups of viruses. Degenerated primers for HRV 
and enteroviruses were designed between the 3′ end of the 
5′ noncoding region (NCR) and the viral protein (VP) 4/
VP2  polyprotein  gene  (TCIGGIARYTTCCASYACCA-
ICC-3′  and  CTGTGTTGAWACYTGAGCICCCA-3′). 
HRVs from positive samples were identified by sequenc-
ing and phylogenetic analysis of these sequences. Ampli-
fied products (about 500 bp, depending on HRV serotype) 
were purified and sequenced in both directions by using 
an automated ABI PRISM 377 model sequencer. Partial 
sequences of HRV have been submitted to GenBank (ac-
cession  nos.  FJ841954–FJ841957,  FJ841959–FJ841961, 
EU697826, and EU697832). Appropriate precautions were 
implemented to avoid false-positive results by carryover 
contamination. Positive results were confirmed by testing 
a second aliquot of the sample stored at –70ºC.
Sixteen infants (8 of each sex) were enrolled in the 
study. All patients were <5 months of age (range 7 days–5 
months, mean age 7.6 weeks, median 4 weeks). Twelve in-
fants had rhinorrea, cough, and distress signs (Table). A 
total of 11 (69%) NPA specimens were positive for at least 
1 viral agent. For 9 of these patients, positive results for 
HRV were confirmed, and for the other 2 patients, respira-
tory syncytial virus was detected.
Phylogenetic analyses of 9 sequences obtained from 
patients showed distribution of HRV in 3 clusters. Three 
sequences  were  included  in  previously  characterized 
clades,  defined  by  HRV  group  A  (HRV-A,  SO4923–
EU697826)  and  B  (HRV-B,  SO3970–FJ841954  and 
SO4998–EU697832).  Sequence  from  patient  SO4923 
had a low sequence similarity with the other serotypes of 
HRV-A. In contrast, sequences from patients SO3970 and 
SO4998 were closely related to HRV-35 and HRV-79, re-
spectively. Six sequences were included in the third group 
corresponding  to  the  new  HRV-C:  SO5854,  SO6666, 
SO5797,  SO6819,  SO5986,  SO6813-  FJ841955-57  and 
FJ841959-61) (3,10) (Figure). Different genotypes (collec-
tively called HRV-Cs) were identified in 6 NPA specimens 
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from children with ALTEs (67% of total HRV). Two re-
ceived cardiopulmonary resuscitation at home; for these 2 
patients, a respiratory syncytial virus and an HRV-C were 
identified. All 16 children survived.
Conclusions
The most common discharge diagnoses reported for 
ALTEs are gastroesophageal reflux disease (GERD), un-
known causes, seizures, and lower respiratory tract infec-
tions (11). Our series suggests that ALTEs of previously 
unknown etiology could be related to HRV infections. Rhi-
novirus infections are known to be a major cause of illness 
and  hospital  admission  for  young  children,  particularly 
infants <2 years of age (12). Detection of viral genomes 
by nested RT-PCR in NPA specimens led us to analyze 
the effect of HRV infections in different clinical situations. 
Respiratory  infections  associated  with  HRV  might  play 
a major role in young infants, probably with few clinical 
signs, and might contribute to apnea as a first manifesta-
tion. GERD is the most frequent hospital discharge diag-
nosis in published series (5,11). For our patients, GERD 
also was the most frequent clinical diagnosis (9 patients), 
but for 7 of them, a respiratory virus was identified. We 
cannot conclude whether GERD is a risk factor for apnea 
or whether signs are so nonspecific that diagnoses could be 
confused.
Alternatively, the new HRV-C group could account 
for as many as a quarter or even half of HRV infections 
(4,13). In children, it has been associated with bronchioli-
tis, wheezing, and asthma exacerbations severe enough to 
require  hospitalization;  the  percentage  of  these  children 
with hypoxia was substantial (13). In a case–control study, 
Khetsuriani et al. (4) found HRV-C only in case-patients, 
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Table.	Characteristics	of	infants	with	ALTEs,	Spain,	November	2004–December	2008*	
Laboratory 
no.
Sex/	
age, wk
Admission
date Clinical	signs Discharge diagnosis Virus Prematurity
SO3970 M/4 2004	Nov	 Cough,	rhinorrea,	loss	of	consciousness,	
flaccidity 
Choking HRV-B No
SO4891 M/4 2005	Oct	 Cyanosis,	loss	of	consciousness, flaccidity  Cyanosis	 No Yes	(35	wk)	
SO4923 M/15 2005	Nov	 Apnea, flushing  Cyanosis	+	URTI	 HRV-A Yes	(36	wk)	
SO4998 F/8 2005	Nov	 Choking,	flushing,	distress	 URTI	+	GERD	 HRV-B No
SO5260 F/9 2006	Apr	 Cough,	choking	 GERD No No
SO5355 M/6 2006	Jun	 Apnea, cyanosis  URTI	+	GERD	 No No
SO5529 F/4 2006	Nov	 Apnea, congestion, cyanosis Bronchiolitis	+	GERD	 RSV No
SO5749 M/24 2007	Mar	 Choking, cyanosis  Wheezing No No
SO5797 F/6 2007	Mar	 Apnea, flushing  Choking	+	GERD	 HRV-C No
SO5854 F/6 2007	Apr	 Cough,	rhinorrea,	apnea	 URTI	+	GERD	 HRV-C No
SO5896 M/13 2007	Sep	 Apnea, rhinorrea  Bronchiolitis	+	GERD	 HRV-C No
SO6012 F/7 2007	Oct	 Cough,	distress,	apnea	 URTI RSV-A No
SO6666 M/4 2008	Oct	 Cyanosis,	choking Choking HRV-C No
SO6813 F/6 2008	Nov	 Apnea, flaccidity  Apnea	+	GERD	 HRV-C No
SO6819 M/6 2008	Nov	 Cough,	rhinorrea,	flushing	 URTI	+	GERD	 HRV-C No
SO6816 F/1 2009	Jan Choking,	flushing Choking No No
*ALTEs, acute life-threatening events;	URTI,	upper	respiratory	tract	infection;	RSV,	respiratory	syncytial	virus;	HRV,	human	rhinovirus;	EV,	enterovirus;	
GERD,	gastroesophageal	reflux	disease.	
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Figure.	Phylogenetic	analysis	of	5′	noncoding	region	and	viral	protein	
(VP)	4/2	coding	region	of	9	human	rhinoviruses	(HRVs)	identified	in	
infants	with	apparently	life-threatening	events	in	Spain,	November	
2004–December	2008.	Phylogeny	of	nucleotide	sequences	(≈492	
bp)	was	reconstructed	with	neighbor-joining	analysis	by	applying	a	
Jukes-Cantor	model;	scale	bar	indicates	nucleotide	substitutions	
per site. Included for reference are sequences belonging to the 
novel	genotype	reported	previously	(QPM	and	024,	025,	026	[11])	
and	all	HRV-A	and	-B	serotypes	available	in	GenBank.	Significant	
bootstrapping is indicated.supporting  the  pathogenic  role  of  this  genogroup.  They 
considered that HRV-C infections could be associated with 
more severe clinical manifestations than infections with 
other HRV genogroups A and B. These data could also 
support the role of HRV-C in infants with ALTEs found 
in this work.
Although we had no control group for our patients, we 
recently published a study of a cohort of 316 newborns up 
to 6 months of age tested weekly for respiratory diseases 
(mainly upper respiratory tract infections), coincident in 
age and time with our patients (14). HRV was present in 5 
(3.6%) of 72 infants tested. Two viruses were genetically 
identified as HRV-C, demonstrating they form distinct ge-
netic clusters, and no genetic similarity was obtained with 
the ALTE–related HRV-C viruses. In addition, a second 
group of asymptomatic children of different ages but in co-
incident epidemic seasons was studied. The group of chil-
dren with HRV was substantially smaller than the group of 
children with respiratory disease (15).
Viral infections could play a major role in ALTEs. 
Rhinoviruses, especially HRV-C, could cause a respiratory 
infection with few symptoms in young infants and could 
trigger ALTEs in this age group. Therefore, HRVs and pos-
terior genotyping should be included in studies of the etiol-
ogy of ALTEs to help identify the true relevance of HRV-C 
infection to these episodes.
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